Webinar “Artificial Intelligence in MedTech” from the European IP Helpdesk and the European Patent Office

When: 26/06/2025 - 26/06/2025
Where: Online

The webinar takes place on Thursday 26th June from 9.30-11.00 (CEST). This lecture series, organised in co-operation with the European IP Helpdesk, addresses the IP-related aspects of EU-funded projects in five areas, including medtech. It introduces the main aspects of IP management: notably IP ownership, protection and exploitation.

Registration HERE

Agenda:

09.30 Introduction - Enrico Luzzatto, Senior advisor, EPO
09.35 Presentation of main aspects of IP management in EU-funded projects - Michele Dubbini, senior IP expert, European IP Helpdesk
09.50 Getting to know patents - Enrico Luzzatto, Senior advisor, EPO
10.10 Patentability of AI in Medical Technologies - Carlos Rivera Pons, Team Manager, EPO
10.35 Learning resources Enrico Luzzatto, Senior advisor, EPO - Michele Dubbini, senior IP expert, European IP Helpdesk
10.45 Q&A
11.00 End

Duration: 75 minutes (presentation) + 15 minutes (Q&As)

Tag: | Events: 401 of 414

All events

News

12/06/2025

Exploring Trust and Public Engagement in in silico medicine at STS Italia 2025

Delegates from the VPH at the Science and Technology Studies Italia (STS Italia) conference in Milan -Read more-

04/06/2025

VPH commends EMA's Mechanistic Modelling Guideline Initiative urging broader scope

On 30 May 2025, VPH presented its formal comments and suggestions on the European Medicines Agency's (EMA) proposed guideline for assessing and reporting mechanistic models in the context of model informed drug development (EMA 2025). -Read more-

04/06/2025

New funding opportunities for the in silico medicine community

The European Commission has announced the Health and Research Infrastructures 2025 Work Programmes and these programmes contain several opportunities in the in silico medicine domain. -Read more-

03/06/2025

News from the 8th VPH Summer School this week in Barcelona

The Summer School provides junior engineers, early researchers and medical doctors with an integrative view of state-of-the-art research for in silico medicine, following a complete pipeline from basic science and clinical needs, to model application. -Read more-

More news

Events